Harmony Biosciences (NASDAQ: HRMY) reported Q1 EPS of $0.51, $0.20 better than the analyst estimate of $0.31. Revenue for the quarter came in at $85.3 million versus the consensus estimate of $89.61 million.

For earnings history and earnings-related data on Harmony Biosciences (HRMY) click here.